• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (4)
    • Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions.
    • Rubinstein, Mark
    • Samuvel, Devadoss
    • The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma.
    • See All 4 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma.

The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma. Mol Cancer Ther. 2016 05; 15(5):1018-28.

View in: PubMed

subject areas
  • Angiogenesis Inhibitors
  • Animals
  • Antineoplastic Agents
  • Azepines
  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • Cell Survival
  • Child
  • Disease Models, Animal
  • Drug Resistance, Neoplasm
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Mice
  • Neovascularization, Pathologic
  • Proto-Oncogene Proteins c-myc
  • Sarcoma
  • Transcription Factor AP-1
  • Triazoles
  • Xenograft Model Antitumor Assays

authors with profiles
  • Denis C Guttridge